Galderisi Alfonso, Schlissel Elise, Cengiz Eda
Division of Pediatric Endocrinology and Diabetes, Yale School of Medicine, 333 Cedar St., P.O. Box 208064, New Haven, CT, 06520, USA.
Department of Women and Children's Health, University of Padova, Padova, Italy.
Curr Diab Rep. 2017 Sep 23;17(11):111. doi: 10.1007/s11892-017-0944-6.
Decades after the invention of insulin pump, diabetes management has encountered a technology revolution with the introduction of continuous glucose monitoring, sensor-augmented insulin pump therapy and closed-loop/artificial pancreas systems. In this review, we discuss the significance of the 2016 Endocrine Society Guidelines for insulin pump therapy and continuous glucose monitoring and summarize findings from relevant diabetes technology studies that were conducted after the publication of the 2016 Endocrine Society Guidelines.
The 2016 Endocrine Society Guidelines have been a great resource for clinicians managing diabetes in this new era of diabetes technology. There is good body of evidence indicating that using diabetes technology systems safely tightens glycemic control while managing both type 1 and type 2 diabetes. The first-generation diabetes technology systems will evolve as we gain more experience and collaboratively work to improve them with an ultimate goal of keeping people with diabetes complication and burden-free until the cure for diabetes becomes a reality.
胰岛素泵发明数十年后，随着持续葡萄糖监测、传感器增强胰岛素泵治疗以及闭环/人工胰腺系统的引入，糖尿病管理迎来了一场技术革命。在本综述中，我们讨论了2016年美国内分泌学会胰岛素泵治疗和持续葡萄糖监测指南的重要性，并总结了2016年美国内分泌学会指南发布后进行的相关糖尿病技术研究的结果。
2016年美国内分泌学会指南为在这个糖尿病技术新时代管理糖尿病的临床医生提供了重要资源。有充分的证据表明，安全使用糖尿病技术系统可在管理1型和2型糖尿病的同时加强血糖控制。随着我们积累更多经验并共同努力改进第一代糖尿病技术系统，其将会不断发展，最终目标是让糖尿病患者无并发症且无负担，直到糖尿病治愈成为现实。
Zotero 插件